Key result
Right subclavian TAVR achieves successful deployment with minimal aortic regurgitation in 5 reported cases.
Why the study?
The right subclavian artery approach is an infrequently used alternative access for TAVR when transfemoral and left subclavian artery routes are contraindicated, presenting anatomical challenges along its course to the aortic root.
Is TAVR via the right subclavian artery approach safe and feasible in patients unsuitable for transfemoral or left subclavian artery access?
Case Report (n=5)
No
Is TAVR via the right subclavian artery approach safe and feasible in patients unsuitable for transfemoral or left subclavian artery access?
The right subclavian artery approach is a safe and feasible alternative access method for TAVR when transfemoral and left subclavian routes are contraindicated.
May support right subclavian TAVR when standard access is unavailable; leaves open need for larger prospective studies.
The right subclavian artery (RSA) approach is an infrequently used alternative-access method for transcatheter aortic valve replacement (TAVR), which may be considered when transfemoral and left subclavian artery (LSA) access routes are contraindicated. The double arterial bend encountered along the course of the RSA to the aortic root makes advancement of the TAVR delivery system more challenging, but can be overcome using a steerable delivery system over an ultra-stiff guidewire. We report 5 cases from our institution of TAVRs performed via the RSA approach in patients with severe aortic stenosis that were unsuitable for transfemoral or LSA access. The procedures were performed under general anesthesia, using a 5-cm infraclavicular incision. In each case, an Edwards Commander Delivery System was advanced through an eSheath over an Innowi guidewire, and an Edwards SAPIEN 3 valve was successfully deployed. The mean fluoroscopy time was 19.5 ± 3.8 minutes. No aortic regurgitation (AR) was present postprocedure for 4 out of 5 cases, and 1 had mild to moderate AR. The length of hospital stay was 2 to 3 days for 4 patients. All patients had an excellent outcome at 12 months post-procedure. The RSA approach is a safe and feasible access method for TAVR, and we recommend that it be considered as the next best access method if transfemoral and LSA approaches are unsuitable.
No takes yet. Share an insight, caveat, or question.
Pisaniello et al. (2021) conducted a case report in Severe aortic stenosis (n=5). Transcatheter aortic valve replacement via the right subclavian artery approach was evaluated on Successful valve deployment and post-procedural aortic regurgitation.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: